Your browser doesn't support javascript.
loading
Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.
Matschiner, Gabriele; Fitzgerald, Mary F; Moebius, Ulrich; Hohlbaum, Andreas M; Gille, Hendrik; Jensen, Kristian; Kirchfeld, Klaus; Rattenstetter, Barbara; Laforge, Alice; Bel Aiba, Rachida S; Ciccotosto, Joe; Nyugen, Hong; Foster, Martyn L; Snouwaert, John N; Nguyen, MyTrang; Koller, Beverly H; Matis, Louis; Anderson, Gary P; Olwill, Shane A.
Afiliación
  • Matschiner G; Pieris Pharmaceuticals, Hallbergmoos, Germany. Electronic address: matschiner@pieris.com.
  • Fitzgerald MF; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Moebius U; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Hohlbaum AM; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Gille H; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Jensen K; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Kirchfeld K; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Rattenstetter B; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Laforge A; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Bel Aiba RS; Pieris Pharmaceuticals, Hallbergmoos, Germany.
  • Ciccotosto J; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
  • Nyugen H; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
  • Foster ML; Experimental Pathology Consultancy, Benfleet, United Kingdom.
  • Snouwaert JN; University of North Carolina, Chapel Hill, NC.
  • Nguyen M; University of North Carolina, Chapel Hill, NC.
  • Koller BH; University of North Carolina, Chapel Hill, NC.
  • Matis L; Pieris Pharmaceuticals, Boston, Mass.
  • Anderson GP; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Electronic address: gpa@unimelb.edu.au.
  • Olwill SA; Pieris Pharmaceuticals, Hallbergmoos, Germany.
J Allergy Clin Immunol ; 151(4): 966-975, 2023 04.
Article en En | MEDLINE | ID: mdl-36592703
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Asma / Interleucina-13 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Asma / Interleucina-13 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article